<?xml version="1.0" ?>
<document id="6d5600b0c8725f08c005efaaf90fe3668aef1c65">
  <chunk id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c0" text="Delivery of IL-35 by Lactococcus lactis Ameliorates Collagen-Induced Arthritis in Mice">
    <entity charOffset="69-78" id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c0.e0" ontology_id="HP_0001369" text="Arthritis" type="phenotype"/>
  </chunk>
  <chunk id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1" text="IL-35, a relatively newly discovered cytokine belonging to the larger IL-12 family, shows unique anti-inflammatory properties, believed to be associated with dedicated receptors and signaling pathways. IL-35 plays a pivotal role in the development and the function of both regulatory B (Bregs) and T cells (Tregs). In order to further its therapeutic potential, a dairy Lactococcus lactis strain was engineered to express murine IL-35 (LL-IL35), and this recombinant strain was applied to suppress collagen-induced arthritis (CIA). Oral administration of LL-IL35 effectively reduced the incidence and disease severity of CIA. When administered therapeutically, LL-IL35 abruptly halted CIA progression with no increase in disease severity by reducing neutrophil influx into the joints. LL-IL35 treatment reduced IFN-γ and IL-17 3.7-and 8.5-fold, respectively, and increased IL-10 production compared to diseased mice. Foxp3 + and Foxp3 − CD39 + CD4 + T cells were previously shown to be the Tregs responsible for conferring protection against CIA. Inquiry into their induction revealed that both CCR6 + and CCR6 − Foxp3 +or− CD39 + CD4 + T cells act as the source of the IL-10 induced by LL-IL35. Thus, this study demonstrates the feasibility and benefits of engineered probiotics for treating autoimmune diseases.">
    <entity charOffset="182-191" id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e0" ontology_id="GO_0023052" text="signaling" type="gene_function"/>
    <entity charOffset="515-524" id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e1" ontology_id="HP_0001369" text="arthritis" type="phenotype"/>
    <entity charOffset="609-617" id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e2" ontology_id="HP_0012824" text="severity" type="phenotype"/>
    <entity charOffset="729-737" id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e3" ontology_id="HP_0012824" text="severity" type="phenotype"/>
    <entity charOffset="873-889" id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e4" ontology_id="GO_0032613" text="IL-10 production" type="gene_function"/>
    <pair e1="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e0" e2="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e1" id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.p0" relation="true"/>
    <pair e1="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e0" e2="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e2" id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.p1" relation="true"/>
    <pair e1="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e0" e2="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e3" id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.p2" relation="true"/>
    <pair e1="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e1" e2="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e4" id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.p3" relation="true"/>
    <pair e1="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e2" e2="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e4" id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.p4" relation="true"/>
    <pair e1="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e3" e2="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.e4" id="6d5600b0c8725f08c005efaaf90fe3668aef1c65.c1.p5" relation="true"/>
  </chunk>
</document>
